↓ Skip to main content

Dove Medical Press

New advances in the treatment of gout: review of pegloticase

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
16 patents

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
51 Mendeley
Title
New advances in the treatment of gout: review of pegloticase
Published in
Therapeutics and Clinical Risk Management, October 2010
DOI 10.2147/tcrm.s6043
Pubmed ID
Authors

Mattheus K Reinders, Tim L Th A Jansen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
United States 1 2%
Unknown 48 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 22%
Student > Ph. D. Student 9 18%
Student > Master 7 14%
Student > Bachelor 5 10%
Professor > Associate Professor 4 8%
Other 10 20%
Unknown 5 10%
Readers by discipline Count As %
Medicine and Dentistry 16 31%
Agricultural and Biological Sciences 9 18%
Biochemistry, Genetics and Molecular Biology 8 16%
Chemistry 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 7 14%
Unknown 6 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#3,798,287
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#188
of 1,323 outputs
Outputs of similar age
#15,246
of 108,269 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 6 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,269 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.